Affordable Access

Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis.

Authors
  • Katz, Jeffry A
  • Antoni, Christian
  • Keenan, Gregory F
  • Smith, Deirdre E
  • Jacobs, Stephen J
  • Lichtenstein, Gary R
Type
Published Article
Journal
The American journal of gastroenterology
Publication Date
Dec 01, 2004
Volume
99
Issue
12
Pages
2385–2392
Identifiers
PMID: 15571587
Source
Medline
License
Unknown

Abstract

Data from the infliximab safety database suggest that infliximab exposure during pregnancy results in outcomes that do not differ from those in the U.S. population of pregnant women and pregnant women with CD not exposed to infliximab. No increased risk of adverse outcome was detected, however, follow-up of larger numbers of pregnant women exposed to infliximab will be necessary to definitively exclude any fetal risk.

Report this publication

Statistics

Seen <100 times